{"transactions":[{"id":4616524,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-09-12T00:10:47.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":732500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":732500,"derivative":{"exercise_price":0.6488,"exercise_date":"2026-10-10","expiration_date":"2036-09-09","underlying":"Common Stock","underlying_shares":732500},"source":{"system":"sec-edgar","filing":"0001193125-26-389563","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526389563/ownership.xml","form_type":"4"}},{"id":4616523,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-12T00:10:47.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":122000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on February 15, 2027, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 384,069 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":539782,"source":{"system":"sec-edgar","filing":"0001193125-26-389563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526389563/ownership.xml","form_type":"4"}},{"id":4616522,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-09-12T00:10:02.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":293000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":293000,"derivative":{"exercise_price":0.6488,"exercise_date":"2026-10-10","expiration_date":"2036-09-09","underlying":"Common Stock","underlying_shares":293000},"source":{"system":"sec-edgar","filing":"0001193125-26-389561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1868494/000119312526389561/ownership.xml","form_type":"4"}},{"id":4616521,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-12T00:10:02.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":49000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. Amended and Restated 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on February 15, 2027, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 142,076 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":263073,"source":{"system":"sec-edgar","filing":"0001193125-26-389561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1868494/000119312526389561/ownership.xml","form_type":"4"}},{"id":685486,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:50:17.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":7406,"price":0.7097,"value":5256.0382,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes 262,069 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":417782,"source":{"system":"sec-edgar","filing":"0001193125-26-354518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526354518/ownership.xml","form_type":"4"}},{"id":685485,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:50:17.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":5020,"price":0.7097,"value":3562.694,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 281,894 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":425188,"source":{"system":"sec-edgar","filing":"0001193125-26-354518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526354518/ownership.xml","form_type":"4"}},{"id":685484,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:50:17.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":3969,"price":0.7098,"value":2817.1962,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 295,331 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":430208,"source":{"system":"sec-edgar","filing":"0001193125-26-354518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526354518/ownership.xml","form_type":"4"}},{"id":685483,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:50:17.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":5837,"price":0.7097,"value":4142.5189,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 305,956 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":434177,"source":{"system":"sec-edgar","filing":"0001193125-26-354518","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526354518/ownership.xml","form_type":"4"}},{"id":685018,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:49:28.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":2279,"price":0.7098,"value":1617.6342,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"Includes 93,076 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":214073,"source":{"system":"sec-edgar","filing":"0001193125-26-354517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526354517/ownership.xml","form_type":"4"}},{"id":685017,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:49:28.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":1871,"price":0.7098,"value":1328.0358,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 99,169 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":216352,"source":{"system":"sec-edgar","filing":"0001193125-26-354517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526354517/ownership.xml","form_type":"4"}},{"id":685016,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:49:28.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":1637,"price":0.7098,"value":1161.9426,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 104,169 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":218223,"source":{"system":"sec-edgar","filing":"0001193125-26-354517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526354517/ownership.xml","form_type":"4"}},{"id":685015,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-18T00:49:28.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":1637,"price":0.7098,"value":1161.9426,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 108,544 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 6,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2026."}],"balance_after":219860,"source":{"system":"sec-edgar","filing":"0001193125-26-354517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526354517/ownership.xml","form_type":"4"}},{"id":709456,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":30454,"kind":"person","name":"Hyllengren Eric J","position":1,"cik":"0001966926","reported_name":"Hyllengren Eric J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-07-15T01:00:51.000Z","date":"2026-07-13","kind":"grant","planned":false,"acquired":true,"shares":1650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2024 Inducement Equity Incentive Plan. Option will vest as to 1/4th of the total number of shares subject to the option on the one-year anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":1650000,"derivative":{"exercise_price":0.8365,"exercise_date":"2027-07-13","expiration_date":"2036-07-12","underlying":"Common Stock","underlying_shares":1650000},"source":{"system":"sec-edgar","filing":"0001193125-26-303681","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526303681/ownership.xml","form_type":"4"}},{"id":758522,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":11492,"kind":"person","name":"Williams R Sanders","position":1,"cik":"0001375347","reported_name":"Williams R Sanders","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-29T23:30:09.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":0.7989,"exercise_date":"2027-05-28","expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-26-249135","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375347/000119312526249135/ownership.xml","form_type":"4"}},{"id":758422,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43108,"kind":"person","name":"Walsh Jeffrey T.","position":1,"cik":"0001578251","reported_name":"Walsh Jeffrey T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-29T23:29:04.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":0.7989,"exercise_date":"2027-05-28","expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-26-249132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578251/000119312526249132/ownership.xml","form_type":"4"}},{"id":758377,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":40090,"kind":"person","name":"Stehman-Breen Catherine","position":1,"cik":"0001702233","reported_name":"Stehman-Breen Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-29T23:28:00.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":0.7989,"exercise_date":"2027-05-28","expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-26-249131","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702233/000119312526249131/ownership.xml","form_type":"4"}},{"id":758289,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43081,"kind":"person","name":"Srivastava Deepak","position":1,"cik":"0001868501","reported_name":"Srivastava Deepak","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-29T23:13:06.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":0.7989,"exercise_date":"2027-05-28","expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-26-249116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526249116/ownership.xml","form_type":"4"}},{"id":758383,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-29T23:09:48.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":0.7989,"exercise_date":"2027-05-28","expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-26-249114","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000119312526249114/ownership.xml","form_type":"4"}},{"id":758378,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-29T23:08:44.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":0.7989,"exercise_date":"2027-05-28","expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-26-249113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696493/000119312526249113/ownership.xml","form_type":"4"}},{"id":758900,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43198,"kind":"person","name":"Burroughs Amy L.","position":1,"cik":"0001872564","reported_name":"Burroughs Amy L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-05-29T23:07:42.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Amended and Restated Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 28, 2027, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":0.7989,"exercise_date":"2027-05-28","expiration_date":"2036-05-27","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001193125-26-249052","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872564/000119312526249052/ownership.xml","form_type":"4"}},{"id":772036,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-19T23:09:59.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":3390,"price":0.7934,"value":2689.626,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 321,581 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":440014,"source":{"system":"sec-edgar","filing":"0001193125-26-231324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526231324/ownership.xml","form_type":"4"}},{"id":770993,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-19T23:09:00.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":3121,"price":0.7936,"value":2476.8256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 112,919 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":215497,"source":{"system":"sec-edgar","filing":"0001193125-26-231323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526231323/ownership.xml","form_type":"4"}},{"id":772708,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2026-05-19T23:06:46.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":1485,"price":0.7932,"value":1177.902,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on August 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 67,938 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":118267,"source":{"system":"sec-edgar","filing":"0001193125-26-231315","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000119312526231315/ownership.xml","form_type":"4"}},{"id":879653,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T16:23:09.000Z","date":"2026-02-25","kind":"sale","planned":false,"acquired":false,"shares":1862545,"price":0.5624,"value":1047495.308,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.55 to $0.641, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by The Column Group III-A, LP (\"TCG III-A LP\"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-076814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526076814/ownership.xml","form_type":"4"}},{"id":879652,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T16:23:09.000Z","date":"2026-02-25","kind":"sale","planned":false,"acquired":false,"shares":1649281,"price":0.5624,"value":927555.6344,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.55 to $0.641, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by The Column Group III, LP (\"TCG III LP\"). TCG III GP is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are Peter Svennilson and Tim Kutzkey (together, the \"Managing Partners\"). The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-076814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526076814/ownership.xml","form_type":"4"}},{"id":879651,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T16:23:09.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":349212,"price":0.6153,"value":214870.1436,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.584 to $0.6392, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by The Column Group III-A, LP (\"TCG III-A LP\"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":1862545,"source":{"system":"sec-edgar","filing":"0001193125-26-076814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526076814/ownership.xml","form_type":"4"}},{"id":879650,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-26T16:23:09.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":309228,"price":0.6153,"value":190267.9884,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.584 to $0.6392, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by The Column Group III, LP (\"TCG III LP\"). TCG III GP is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are Peter Svennilson and Tim Kutzkey (together, the \"Managing Partners\"). The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":1649281,"source":{"system":"sec-edgar","filing":"0001193125-26-076814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526076814/ownership.xml","form_type":"4"}},{"id":884848,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T16:13:06.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":162291,"price":0.5972,"value":96920.1852,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.573 to $0.6225, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by The Column Group III-A, LP (\"TCG III-A LP\"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":2211757,"source":{"system":"sec-edgar","filing":"0001193125-26-067007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526067007/ownership.xml","form_type":"4"}},{"id":884847,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T16:13:06.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":143709,"price":0.5972,"value":85823.0148,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.573 to $0.6225, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by The Column Group III, LP (\"TCG III LP\"). TCG III GP is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are Peter Svennilson and Tim Kutzkey (together, the \"Managing Partners\"). The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":1958509,"source":{"system":"sec-edgar","filing":"0001193125-26-067007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526067007/ownership.xml","form_type":"4"}},{"id":884846,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T16:13:06.000Z","date":"2026-02-20","kind":"sale","planned":false,"acquired":false,"shares":277769,"price":0.6149,"value":170800.1581,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.60 to $0.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by The Column Group III-A, LP (\"TCG III-A LP\"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":2374048,"source":{"system":"sec-edgar","filing":"0001193125-26-067007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526067007/ownership.xml","form_type":"4"}},{"id":884845,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-24T16:13:06.000Z","date":"2026-02-20","kind":"sale","planned":false,"acquired":false,"shares":245965,"price":0.6149,"value":151243.8785,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.60 to $0.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by The Column Group III, LP (\"TCG III LP\"). TCG III GP is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are Peter Svennilson and Tim Kutzkey (together, the \"Managing Partners\"). The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":2102218,"source":{"system":"sec-edgar","filing":"0001193125-26-067007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526067007/ownership.xml","form_type":"4"}},{"id":901492,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2026-02-18T00:15:32.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":2022,"price":0.6431,"value":1300.3482,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 71,688 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":119752,"source":{"system":"sec-edgar","filing":"0001193125-26-055445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000119312526055445/ownership.xml","form_type":"4"}},{"id":901491,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2026-02-18T00:15:32.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":836,"price":0.6434,"value":537.8824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 76,376 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":121774,"source":{"system":"sec-edgar","filing":"0001193125-26-055445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000119312526055445/ownership.xml","form_type":"4"}},{"id":901490,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2026-02-18T00:15:32.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":611,"price":0.6434,"value":393.1174,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 78,314 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":122610,"source":{"system":"sec-edgar","filing":"0001193125-26-055445","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000119312526055445/ownership.xml","form_type":"4"}},{"id":900995,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:14:17.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":5032,"price":0.643,"value":3235.576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 330,187 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":443404,"source":{"system":"sec-edgar","filing":"0001193125-26-055442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526055442/ownership.xml","form_type":"4"}},{"id":900994,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:14:17.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":3979,"price":0.6431,"value":2558.8949,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 343,625 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":448436,"source":{"system":"sec-edgar","filing":"0001193125-26-055442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526055442/ownership.xml","form_type":"4"}},{"id":900993,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:14:17.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":5851,"price":0.643,"value":3762.193,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 354,250 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":452415,"source":{"system":"sec-edgar","filing":"0001193125-26-055442","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526055442/ownership.xml","form_type":"4"}},{"id":900248,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:13:30.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":1876,"price":0.6431,"value":1206.4556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 120,838 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":218618,"source":{"system":"sec-edgar","filing":"0001193125-26-055439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526055439/ownership.xml","form_type":"4"}},{"id":900247,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:13:30.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":1642,"price":0.6432,"value":1056.1344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 125,838 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":220494,"source":{"system":"sec-edgar","filing":"0001193125-26-055439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526055439/ownership.xml","form_type":"4"}},{"id":900246,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:13:30.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":1642,"price":0.6432,"value":1056.1344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 130,213 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 5,102 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2025."}],"balance_after":222136,"source":{"system":"sec-edgar","filing":"0001193125-26-055439","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526055439/ownership.xml","form_type":"4"}},{"id":907577,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-12T17:19:03.000Z","date":"2026-02-11","kind":"sale","planned":false,"acquired":false,"shares":2151458,"price":0.6808,"value":1464712.6064,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.65 to $0.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by The Column Group III-A, LP (\"TCG III-A LP\"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":2651817,"source":{"system":"sec-edgar","filing":"0001193125-26-049028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526049028/ownership.xml","form_type":"4"}},{"id":907576,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-12T17:19:03.000Z","date":"2026-02-11","kind":"sale","planned":false,"acquired":false,"shares":1905115,"price":0.6808,"value":1297002.292,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.65 to $0.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by The Column Group III, LP (\"TCG III LP\"). TCG III GP is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are Peter Svennilson and Tim Kutzkey (together, the \"Managing Partners\"). The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":2348183,"source":{"system":"sec-edgar","filing":"0001193125-26-049028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526049028/ownership.xml","form_type":"4"}},{"id":907575,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-12T17:19:03.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":182295,"price":0.8161,"value":148770.9495,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by The Column Group III-A, LP (\"TCG III-A LP\"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":4803275,"source":{"system":"sec-edgar","filing":"0001193125-26-049028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526049028/ownership.xml","form_type":"4"}},{"id":907574,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":45898,"kind":"person","name":"Kutzkey Tim","position":7,"cik":"0001614186","reported_name":"Kutzkey Tim","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64492,"kind":"person","name":"Svennilson Peter","position":8,"cik":"0001606074","reported_name":"Svennilson Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-12T17:19:03.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":161422,"price":0.8161,"value":131736.4942,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by The Column Group III, LP (\"TCG III LP\"). TCG III GP is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are Peter Svennilson and Tim Kutzkey (together, the \"Managing Partners\"). The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares."}],"balance_after":4253298,"source":{"system":"sec-edgar","filing":"0001193125-26-049028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000119312526049028/ownership.xml","form_type":"4"}},{"id":918017,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-05T23:03:28.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":175500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":175500,"derivative":{"exercise_price":0.915,"exercise_date":"2026-03-03","expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":175500},"source":{"system":"sec-edgar","filing":"0001193125-26-039768","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000119312526039768/ownership.xml","form_type":"4"}},{"id":918016,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2026-02-05T23:03:28.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":29250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2026, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 79,720 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":123221,"source":{"system":"sec-edgar","filing":"0001193125-26-039768","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000119312526039768/ownership.xml","form_type":"4"}},{"id":917212,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-05T23:02:44.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":318500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":318500,"derivative":{"exercise_price":0.915,"exercise_date":"2026-03-03","expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":318500},"source":{"system":"sec-edgar","filing":"0001193125-26-039763","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526039763/ownership.xml","form_type":"4"}},{"id":917211,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-05T23:02:44.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":48750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2026, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 134,588 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":223778,"source":{"system":"sec-edgar","filing":"0001193125-26-039763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312526039763/ownership.xml","form_type":"4"}},{"id":917718,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-05T23:02:09.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":952250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":952250,"derivative":{"exercise_price":0.915,"exercise_date":"2026-03-03","expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":952250},"source":{"system":"sec-edgar","filing":"0001193125-26-039760","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526039760/ownership.xml","form_type":"4"}},{"id":917717,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-05T23:02:09.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":158600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2026, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 369,875 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":458266,"source":{"system":"sec-edgar","filing":"0001193125-26-039760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312526039760/ownership.xml","form_type":"4"}},{"id":998067,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2025-11-18T01:34:59.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":1367,"price":1.33,"value":1818.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on August 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 50,470 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":93971,"source":{"system":"sec-edgar","filing":"0001193125-25-284999","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000119312525284999/ownership.xml","form_type":"4"}},{"id":997431,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-18T01:34:13.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":2877,"price":1.33,"value":3826.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 85,838 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":169926,"source":{"system":"sec-edgar","filing":"0001193125-25-284997","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000119312525284997/ownership.xml","form_type":"4"}},{"id":997741,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-11-18T01:33:38.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":3126,"price":1.33,"value":4157.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 211,275 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":299666,"source":{"system":"sec-edgar","filing":"0001193125-25-284996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000119312525284996/ownership.xml","form_type":"4"}},{"id":1064266,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2025-08-19T01:00:03.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1722,"price":1.253,"value":2157.666,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 54,220 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":95338,"source":{"system":"sec-edgar","filing":"0000950170-25-109915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000095017025109915/ownership.xml","form_type":"4"}},{"id":1064265,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2025-08-19T01:00:03.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":717,"price":1.253,"value":898.401,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 58,907 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":97060,"source":{"system":"sec-edgar","filing":"0000950170-25-109915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000095017025109915/ownership.xml","form_type":"4"}},{"id":1064264,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2025-08-19T01:00:03.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":523,"price":1.253,"value":655.319,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 60,844 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":97777,"source":{"system":"sec-edgar","filing":"0000950170-25-109915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000095017025109915/ownership.xml","form_type":"4"}},{"id":1063453,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:59:15.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1837,"price":1.253,"value":2301.761,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 93,757 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":172803,"source":{"system":"sec-edgar","filing":"0001868494-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000186849425000006/ownership.xml","form_type":"4"}},{"id":1063452,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:59:15.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1608,"price":1.253,"value":2014.824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 98,757 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":174640,"source":{"system":"sec-edgar","filing":"0001868494-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000186849425000006/ownership.xml","form_type":"4"}},{"id":1063451,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:59:15.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":1608,"price":1.253,"value":2014.824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 103,132 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 6,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2025."}],"balance_after":176248,"source":{"system":"sec-edgar","filing":"0001868494-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000186849425000006/ownership.xml","form_type":"4"}},{"id":1063912,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:58:29.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":4920,"price":1.253,"value":6164.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 219,881 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":302792,"source":{"system":"sec-edgar","filing":"0001667937-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000166793725000006/ownership.xml","form_type":"4"}},{"id":1063911,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:58:29.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":3893,"price":1.253,"value":4877.929,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 233,318 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":307712,"source":{"system":"sec-edgar","filing":"0001667937-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000166793725000006/ownership.xml","form_type":"4"}},{"id":1063910,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-19T00:58:29.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":5720,"price":1.253,"value":7167.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.18 to $1.32. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 243,943 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":311605,"source":{"system":"sec-edgar","filing":"0001667937-25-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000166793725000006/ownership.xml","form_type":"4"}},{"id":1128869,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":40090,"kind":"person","name":"Stehman-Breen Catherine","position":1,"cik":"0001702233","reported_name":"Stehman-Breen Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-05-30T22:54:13.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":107400,"derivative":{"exercise_price":0.4444,"exercise_date":"2026-05-29","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0000950170-25-079950","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702233/000095017025079950/ownership.xml","form_type":"4"}},{"id":1128908,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43108,"kind":"person","name":"Walsh Jeffrey T.","position":1,"cik":"0001578251","reported_name":"Walsh Jeffrey T.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-05-30T22:53:37.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":107400,"derivative":{"exercise_price":0.4444,"exercise_date":"2026-05-29","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0000950170-25-079949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1578251/000095017025079949/ownership.xml","form_type":"4"}},{"id":1129385,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43198,"kind":"person","name":"Burroughs Amy L.","position":1,"cik":"0001872564","reported_name":"Burroughs Amy L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-05-30T22:52:57.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":107400,"derivative":{"exercise_price":0.4444,"exercise_date":"2026-05-29","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0000950170-25-079948","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872564/000095017025079948/ownership.xml","form_type":"4"}},{"id":1128984,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":11492,"kind":"person","name":"Williams R Sanders","position":1,"cik":"0001375347","reported_name":"Williams R Sanders","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-05-30T22:51:21.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":107400,"derivative":{"exercise_price":0.4444,"exercise_date":"2026-05-29","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0000950170-25-079946","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1375347/000095017025079946/ownership.xml","form_type":"4"}},{"id":1128808,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43081,"kind":"person","name":"Srivastava Deepak","position":1,"cik":"0001868501","reported_name":"Srivastava Deepak","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-05-30T22:50:50.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":107400,"derivative":{"exercise_price":0.4444,"exercise_date":"2026-05-29","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0000950170-25-079944","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025079944/ownership.xml","form_type":"4"}},{"id":1128871,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":43099,"kind":"person","name":"Lee June","position":1,"cik":"0001696493","reported_name":"Lee June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-05-30T22:50:27.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":107400,"derivative":{"exercise_price":0.4444,"exercise_date":"2026-05-29","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0000950170-25-079943","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1696493/000095017025079943/ownership.xml","form_type":"4"}},{"id":1128874,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":26580,"kind":"person","name":"Parschauer Karah Herdman","position":1,"cik":"0001677455","reported_name":"Parschauer Karah Herdman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-05-30T22:48:35.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":107400,"derivative":{"exercise_price":0.4444,"exercise_date":"2026-05-29","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0000950170-25-079941","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1677455/000095017025079941/ownership.xml","form_type":"4"}},{"id":1129171,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":79074,"kind":"person","name":"GOEDDEL DAVID V","position":1,"cik":"0001182464","reported_name":"GOEDDEL DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-05-30T18:52:21.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":107400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full May 29, 2026, or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":107400,"derivative":{"exercise_price":0.4444,"exercise_date":"2026-05-29","expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":107400},"source":{"system":"sec-edgar","filing":"0000950170-25-079947","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182464/000095017025079947/ownership.xml","form_type":"4"}},{"id":1145842,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2025-05-16T23:07:53.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":1390,"price":0.4427,"value":615.353,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on August 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 62,250 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":98300,"source":{"system":"sec-edgar","filing":"0000950170-25-073825","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000095017025073825/ownership.xml","form_type":"4"}},{"id":1144604,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-05-16T23:07:25.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":2937,"price":0.4427,"value":1300.2099,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 107,507 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":171856,"source":{"system":"sec-edgar","filing":"0000950170-25-073824","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025073824/ownership.xml","form_type":"4"}},{"id":1145374,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-16T23:07:01.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":3189,"price":0.4427,"value":1411.7703,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 259,568 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":317325,"source":{"system":"sec-edgar","filing":"0000950170-25-073823","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025073823/ownership.xml","form_type":"4"}},{"id":1215540,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2025-03-11T01:44:50.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":845,"price":0.5384,"value":454.948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 66,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":99690,"source":{"system":"sec-edgar","filing":"0000950170-25-036774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000095017025036774/ownership.xml","form_type":"4"}},{"id":1215539,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2025-03-11T01:44:50.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":620,"price":0.5384,"value":333.808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 67,938 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":100535,"source":{"system":"sec-edgar","filing":"0000950170-25-036774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000095017025036774/ownership.xml","form_type":"4"}},{"id":1215538,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":46061,"kind":"person","name":"Higa Tomohiro","position":1,"cik":"0002054280","reported_name":"Higa Tomohiro","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance"}}],"security":"Common Stock","published_at":"2025-03-11T01:44:50.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":1017,"price":0.5384,"value":547.5528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on October 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 69,345 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":101155,"source":{"system":"sec-edgar","filing":"0000950170-25-036774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2054280/000095017025036774/ownership.xml","form_type":"4"}},{"id":1214360,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-11T01:43:12.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":1598,"price":0.5384,"value":860.3632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes 115,426 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":174793,"source":{"system":"sec-edgar","filing":"0000950170-25-036772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025036772/ownership.xml","form_type":"4"}},{"id":1214359,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-11T01:43:12.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":4073,"price":0.5384,"value":2192.9032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 119,801 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":176391,"source":{"system":"sec-edgar","filing":"0000950170-25-036772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025036772/ownership.xml","form_type":"4"}},{"id":1214358,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-11T01:43:12.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":1727,"price":0.5384,"value":929.8168,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 131,051 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 3,409 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2024."}],"balance_after":180464,"source":{"system":"sec-edgar","filing":"0000950170-25-036772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025036772/ownership.xml","form_type":"4"}},{"id":1215058,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-11T01:42:17.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":3947,"price":0.5384,"value":2125.0648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 268,174 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":320514,"source":{"system":"sec-edgar","filing":"0000950170-25-036770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025036770/ownership.xml","form_type":"4"}},{"id":1215057,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-11T01:42:17.000Z","date":"2025-03-10","kind":"sale","planned":false,"acquired":false,"shares":5794,"price":0.5384,"value":3119.4896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 278,799 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":324461,"source":{"system":"sec-edgar","filing":"0000950170-25-036770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025036770/ownership.xml","form_type":"4"}},{"id":1217404,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Warrant (right to buy)","published_at":"2025-03-07T19:14:40.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":17857142,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an underwritten public offering, The Column Group Opportunity III, LP (\"TCG Opportunity III LP\") purchased units (the \"Units\") at a price per Unit of $0.70 per Unit. Each Unit consists of (a) one share of the Issuer's common stock, par value $0.0001 per share (the \"Common Stock\", and such shares, the \"Shares\"), (b) one Series A warrant to purchase one share of Common Stock at an exercise price of $0.80 per share which will expire five years from the date of issuance (a \"Series A Warrant\") and (c) one half of a Series B warrant to purchase a share of Common Stock at an exercise price of $0.70 per share that will expire on June 30, 2026 (a \"Series B Warrant\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each Series B Warrant is immediately exercisable (subject to certain beneficial ownership limitations)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by TCG Opportunity III LP. The Column Group Opportunity III GP, LP (\"TCG Opportunity III GP LP\") is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP, LLC (\"TCG Opportunity III GP LLC\") is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing members of TCG Opportunity III GP LLC are David Goeddel, a member of the Issuer's board of directors, Peter Svennilson and Tim Kutzkey (collectively, the \"Managing Partners\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such securities. TCG Opportunity III GP LP, TCG Opportunity III GP LLC and each of the Managing Partners disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interest in such securities."}],"balance_after":17857142,"derivative":{"exercise_price":0.7,"expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":17857142},"source":{"system":"sec-edgar","filing":"0000950170-25-035789","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000095017025035789/ownership.xml","form_type":"4"}},{"id":1217403,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Warrant (right to buy)","published_at":"2025-03-07T19:14:40.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":35714284,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an underwritten public offering, The Column Group Opportunity III, LP (\"TCG Opportunity III LP\") purchased units (the \"Units\") at a price per Unit of $0.70 per Unit. Each Unit consists of (a) one share of the Issuer's common stock, par value $0.0001 per share (the \"Common Stock\", and such shares, the \"Shares\"), (b) one Series A warrant to purchase one share of Common Stock at an exercise price of $0.80 per share which will expire five years from the date of issuance (a \"Series A Warrant\") and (c) one half of a Series B warrant to purchase a share of Common Stock at an exercise price of $0.70 per share that will expire on June 30, 2026 (a \"Series B Warrant\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Series A Warrant is immediately exercisable (subject to certain beneficial ownership limitations)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by TCG Opportunity III LP. The Column Group Opportunity III GP, LP (\"TCG Opportunity III GP LP\") is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP, LLC (\"TCG Opportunity III GP LLC\") is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing members of TCG Opportunity III GP LLC are David Goeddel, a member of the Issuer's board of directors, Peter Svennilson and Tim Kutzkey (collectively, the \"Managing Partners\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such securities. TCG Opportunity III GP LP, TCG Opportunity III GP LLC and each of the Managing Partners disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interest in such securities."}],"balance_after":35714284,"derivative":{"exercise_price":0.8,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":35714284},"source":{"system":"sec-edgar","filing":"0000950170-25-035789","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000095017025035789/ownership.xml","form_type":"4"}},{"id":1217402,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":64486,"kind":"organization","name":"COLUMN GROUP III GP, LP","position":1,"cik":"0001790965","reported_name":"COLUMN GROUP III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64487,"kind":"organization","name":"COLUMN GROUP III, LP","position":2,"cik":"0001668159","reported_name":"COLUMN GROUP III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64488,"kind":"organization","name":"COLUMN GROUP III-A, LP","position":3,"cik":"0001668085","reported_name":"COLUMN GROUP III-A, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64489,"kind":"organization","name":"Column Group Opportunity III, LP","position":4,"cik":"0001931825","reported_name":"Column Group Opportunity III, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64490,"kind":"organization","name":"Column Group Opportunity III GP, LP","position":5,"cik":"0001932874","reported_name":"Column Group Opportunity III GP, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":64491,"kind":"organization","name":"TCG Opportunity III GP, LLC","position":6,"cik":"0001932445","reported_name":"TCG Opportunity III GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T19:14:40.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":35714284,"price":0.7,"value":24999998.8,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an underwritten public offering, The Column Group Opportunity III, LP (\"TCG Opportunity III LP\") purchased units (the \"Units\") at a price per Unit of $0.70 per Unit. Each Unit consists of (a) one share of the Issuer's common stock, par value $0.0001 per share (the \"Common Stock\", and such shares, the \"Shares\"), (b) one Series A warrant to purchase one share of Common Stock at an exercise price of $0.80 per share which will expire five years from the date of issuance (a \"Series A Warrant\") and (c) one half of a Series B warrant to purchase a share of Common Stock at an exercise price of $0.70 per share that will expire on June 30, 2026 (a \"Series B Warrant\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by TCG Opportunity III LP. The Column Group Opportunity III GP, LP (\"TCG Opportunity III GP LP\") is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP, LLC (\"TCG Opportunity III GP LLC\") is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing members of TCG Opportunity III GP LLC are David Goeddel, a member of the Issuer's board of directors, Peter Svennilson and Tim Kutzkey (collectively, the \"Managing Partners\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such securities. TCG Opportunity III GP LP, TCG Opportunity III GP LLC and each of the Managing Partners disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interest in such securities."}],"balance_after":49313559,"source":{"system":"sec-edgar","filing":"0000950170-25-035789","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668085/000095017025035789/ownership.xml","form_type":"4"}},{"id":1217279,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":79074,"kind":"person","name":"GOEDDEL DAVID V","position":1,"cik":"0001182464","reported_name":"GOEDDEL DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Warrant (right to buy)","published_at":"2025-03-07T19:14:15.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":17857142,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an underwritten public offering, The Column Group Opportunity III, LP (\"TCG Opportunity III LP\") purchased units (the \"Units\") at a price per Unit of $0.70 per Unit. Each Unit consists of (a) one share of the Issuer's common stock, par value $0.0001 per share (the \"Common Stock\", and such shares, the \"Shares\"), (b) one Series A warrant to purchase one share of Common Stock at an exercise price of $0.80 per share which will expire five years from the date of issuance (a \"Series A Warrant\") and (c) one half of a Series B warrant to purchase a share of Common Stock at an exercise price of $0.70 per share that will expire on June 30, 2026 (a \"Series B Warrant\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each Series B Warrant is immediately exercisable (subject to certain beneficial ownership limitations)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by TCG Opportunity III LP. The Column Group Opportunity III GP, LP (\"TCG Opportunity III GP LP\") is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP, LLC (\"TCG Opportunity III GP LLC\") is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing members of TCG Opportunity III GP LLC are David Goeddel, a member of the Issuer's board of directors, Peter Svennilson and Tim Kutzkey (collectively, the \"Managing Partners\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such securities. TCG Opportunity III GP LP, TCG Opportunity III GP LLC and each of the Managing Partners disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interest in such securities."}],"balance_after":17857142,"derivative":{"exercise_price":0.7,"expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":17857142},"source":{"system":"sec-edgar","filing":"0000950170-25-035788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1182464/000095017025035788/ownership.xml","form_type":"4"}},{"id":1217278,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":79074,"kind":"person","name":"GOEDDEL DAVID V","position":1,"cik":"0001182464","reported_name":"GOEDDEL DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Warrant (right to buy)","published_at":"2025-03-07T19:14:15.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":35714284,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an underwritten public offering, The Column Group Opportunity III, LP (\"TCG Opportunity III LP\") purchased units (the \"Units\") at a price per Unit of $0.70 per Unit. Each Unit consists of (a) one share of the Issuer's common stock, par value $0.0001 per share (the \"Common Stock\", and such shares, the \"Shares\"), (b) one Series A warrant to purchase one share of Common Stock at an exercise price of $0.80 per share which will expire five years from the date of issuance (a \"Series A Warrant\") and (c) one half of a Series B warrant to purchase a share of Common Stock at an exercise price of $0.70 per share that will expire on June 30, 2026 (a \"Series B Warrant\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Series A Warrant is immediately exercisable (subject to certain beneficial ownership limitations)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by TCG Opportunity III LP. The Column Group Opportunity III GP, LP (\"TCG Opportunity III GP LP\") is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP, LLC (\"TCG Opportunity III GP LLC\") is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing members of TCG Opportunity III GP LLC are David Goeddel, a member of the Issuer's board of directors, Peter Svennilson and Tim Kutzkey (collectively, the \"Managing Partners\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such securities. TCG Opportunity III GP LP, TCG Opportunity III GP LLC and each of the Managing Partners disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interest in such securities."}],"balance_after":35714284,"derivative":{"exercise_price":0.8,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":35714284},"source":{"system":"sec-edgar","filing":"0000950170-25-035788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1182464/000095017025035788/ownership.xml","form_type":"4"}},{"id":1217277,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":79074,"kind":"person","name":"GOEDDEL DAVID V","position":1,"cik":"0001182464","reported_name":"GOEDDEL DAVID V","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-07T19:14:15.000Z","date":"2025-03-05","kind":"purchase","planned":false,"acquired":true,"shares":35714284,"price":0.7,"value":24999998.8,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an underwritten public offering, The Column Group Opportunity III, LP (\"TCG Opportunity III LP\") purchased units (the \"Units\") at a price per Unit of $0.70 per Unit. Each Unit consists of (a) one share of the Issuer's common stock, par value $0.0001 per share (the \"Common Stock\", and such shares, the \"Shares\"), (b) one Series A warrant to purchase one share of Common Stock at an exercise price of $0.80 per share which will expire five years from the date of issuance (a \"Series A Warrant\") and (c) one half of a Series B warrant to purchase a share of Common Stock at an exercise price of $0.70 per share that will expire on June 30, 2026 (a \"Series B Warrant\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by TCG Opportunity III LP. The Column Group Opportunity III GP, LP (\"TCG Opportunity III GP LP\") is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP, LLC (\"TCG Opportunity III GP LLC\") is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing members of TCG Opportunity III GP LLC are David Goeddel, a member of the Issuer's board of directors, Peter Svennilson and Tim Kutzkey (collectively, the \"Managing Partners\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such securities. TCG Opportunity III GP LP, TCG Opportunity III GP LLC and each of the Managing Partners disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interest in such securities."}],"balance_after":49313559,"source":{"system":"sec-edgar","filing":"0000950170-25-035788","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1182464/000095017025035788/ownership.xml","form_type":"4"}},{"id":1278758,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":401390,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/48th of the shares underying the option vested on March 15, 2022, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":401390,"derivative":{"exercise_price":1.21,"exercise_date":"2022-03-15","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":401390},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278757,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":401390,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/48th of the shares underying the option vested on March 15, 2022, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":15.19,"exercise_date":"2022-03-15","expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":401390},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278756,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":161214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"1/48th of the shares underying the option vested on July 17, 2021, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":161214,"derivative":{"exercise_price":1.21,"exercise_date":"2021-07-17","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":161214},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278755,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":161214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"1/48th of the shares underying the option vested on July 17, 2021, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":9.36,"exercise_date":"2021-07-17","expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":161214},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278754,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":353271,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying the option are fully vested and exercisable."}],"balance_after":353271,"derivative":{"exercise_price":1.21,"exercise_date":"2021-03-27","expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":353271},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278753,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":353271,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on February 6, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices greater than $5.25 per share held by Reporting Person as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share. However, if the Reporting Person exercises a repriced option before the end of a \"Retention Period\" that begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2021 Equity Incentive Plan, then the Reporting Person will be required to pay a premium exercise price that is equal to the original exercise price per share of such option. There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares underlying the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.64,"exercise_date":"2021-03-27","expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":353271},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278752,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest as to 1/48th of the total number of shares subject to the option on the one month anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested."}],"balance_after":650000,"derivative":{"exercise_price":1,"exercise_date":"2025-03-06","expiration_date":"2035-03-05","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278751,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":34424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F4","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the total number of shares subject to the restricted stock unit award on May 15, 2025, and 1/4th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 294,424 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":330255,"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1278750,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22876,"kind":"person","name":"Ali Faraz","position":1,"cik":"0001667937","reported_name":"Ali Faraz","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-08T01:29:29.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":107500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Tenaya Therapeutics, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. The restricted stock units will vest as to 1/8th of the total number of shares subject to the restricted stock unit award on August 15, 2025, and 1/8th of the total number of shares subject to the restricted stock unit award every six months thereafter until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 260,000 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":295831,"source":{"system":"sec-edgar","filing":"0000950170-25-016582","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667937/000095017025016582/ownership.xml","form_type":"4"}},{"id":1292682,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":215000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"1/48th of the shares underying the option vested on March 23, 2024, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":215000,"derivative":{"exercise_price":1.21,"exercise_date":"2024-03-23","expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292681,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":215000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"1/48th of the shares underying the option vested on March 23, 2024, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":5.22,"exercise_date":"2024-03-23","expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":215000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292680,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"grant","planned":false,"acquired":true,"shares":205000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/48th of the shares underying the option vested on March 15, 2023, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":205000,"derivative":{"exercise_price":1.21,"exercise_date":"2023-03-15","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":205000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}},{"id":1292679,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":22735,"kind":"person","name":"Tingley Whittemore","position":1,"cik":"0001868494","reported_name":"Tingley Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-29T01:00:12.000Z","date":"2025-01-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":205000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on January 24, 2025 (the \"Effective Date\"). The Option Repricing applies to nonstatutory options with exercise prices equal to or greater than $3.00 per share held by all continuing employees and certain other service providers of the Issuer as of the Effective Date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Option Repricing, the exercise price of the repriced options, including the reported option, has been amended to reduce the exercise price to $1.21 per share, the closing price of the Issuer's common stock on the Effective Date. However, if an option holder exercises a repriced option before the end of a \"Retention Period\" through which the option holder must remain in service to the Issuer, then the option holder will be required to pay a premium exercise price that is equal to the original exercise price per share of such option.  The \"Retention Period\" begins on the Effective Date of the Option Repricing and ends on the earliest to occur of the following: (i) July 24, 2025 or (ii) a Change in Control, as defined in the Issuer's 2016 Equity Incentive Plan or 2021 Equity Incentive Plan (as applicable). There was no change to the vesting schedules, expiration dates or number of shares underlying the repriced options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/48th of the shares underying the option vested on March 15, 2023, and the remaining shares vest in 48 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.06,"exercise_date":"2023-03-15","expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":205000},"source":{"system":"sec-edgar","filing":"0000950170-25-010075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1858848/000095017025010075/ownership.xml","form_type":"4"}}],"next_cursor":"2025-01-29T01:00:12.000000Z,1292679"}